Evidence map›Paper›PMID 35753337›Full record

ArticleLancet (London, England)2022

Global burden of antimicrobial resistance: essential pieces of a global puzzle.

Denis Mukwege, Prudence Mitangala, Aline Byabene, Emmanuel Busha, Yves Van Laethem, Olivier Vandenberg

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Lancet (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Denis MukwegeDepartment of Gynaecology and General Surgery, Panzi General Referral Hospital, Bukavu, Democratic Republic of the Congo; Faculty of Medicine, Evangelical University in Africa, Bukavu, Democratic Republic of the Congo.
Prudence MitangalaLaboratoire Provincial du Nord-Kivu, Goma, Democratic Republic of the Congo; Faculty of Medicine, Université Officielle de Ruwenzori, Goma, Democratic Republic of the Congo.
Aline ByabeneDepartment of Internal Medicine, Panzi General Referral Hospital, Bukavu, Democratic Republic of the Congo.
Emmanuel BushaFaculty of Medicine, Université Libre des Pays des Grands Lacs, Goma, Democratic Republic of the Congo; Samaritan Paediatric Centre/Samaritan Doctors, Goma, Democratic Republic of the Congo.
Yves Van LaethemDepartment of Infectiology, Saint-Pierre University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Olivier VandenbergCentre for Environmental Health and Occupational Health, School of Public Health, Université Libre de Bruxelles, Brussels, Belgium; Division of Infection and Immunity, Faculty of Medical Sciences, University College London, London, UK; Innovation and Business Development Unit, Laboratoire Hospitalier Universtaire de Bruxelles- Universitair Laboratorium Brussel, Université Libre de Bruxelles, 1000 Brussels, Belgium. Electronic address: olivier.vandenberg@ulb.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialHumansAnti-Bacterial Agents

Identifiers

PMID35753337

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.